Eva Blondeaux contribution to redefining risk in HR+/HER2− early breast cancer
We are pleased to highlight the contribution of Dr. Eva Blondeaux to the latest publication in the Journal of the National Cancer Institute (published February 5, 2025), titled:“Prognostic implications of…








